COMMUNIQUÉS West-GlobeNewswire

PositiveID’s Chairman and CEO Addresses Stockholders
26/04/2018
DELRAY BEACH, Fla., April 26, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTC:PSIDD), a life sciences company focused on detection and diagnostics, announced today that its Chairman and [...]
Aduro Biotech Presents Early Observations From its Personalized Neoantigen-based pLADD Therapy Clinical Study at European Neoantigen Summit
26/04/2018
pLADD Therapy Found to Induce Both Innate and Adaptive Immunity BERKELEY, Calif., April 26, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq: ADRO ) today presented preliminary observations from a case study of a [...]
Tauriga Sciences Inc. Announces Cancellation of Final Remaining Back-End Convertible Debenture Held by GS Capital Partners LLC in Connection with the $105,000 Face Value 8% Convertible Debenture Dated October 17, 2017
26/04/2018
NEW YORK, NY, April 26, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of proprietary [...]
BioNovelus Receives Organic Certification for CR-10®
26/04/2018
FOR IMMEDIATE RELEASE — Phoenix, April 26, 2018 (GLOBE NEWSWIRE) -- — BioNovelus is proud to announce that its flagship product CR-10®, a non-toxic, organic fungicide has received the organic certification from Mayacert [...]
INSYS Therapeutics and University of California (UC) San Diego Center for Medicinal Cannabis Research to Collaborate on Clinical Trial
26/04/2018
Company’s pharmaceutical-grade cannabidiol (CBD) oral solution will be evaluated by UC San Diego/CMCR researchers as potential treatment for symptoms of autism PHOENIX, April 26, 2018 (GLOBE NEWSWIRE) -- NSYS [...]
Krystal Biotech Announces FDA Clearance of IND on KB103 to Begin Enrolling Patients for the Treatment of Dystrophic Epidermolysis Bullosa
26/04/2018
KB103 is the first-ever herpes simplex virus ( HSV-1) based topical gene therapy candidate engineered to produce human collagen protein to treat dystrophic epidermolysis bullosa (DEB) The planned Phase 1/2 KB103 single [...]
Poseida Therapeutics Presents Clinical Manufacturing Method for Durable, Persistent CAR-T Stem Cell Memory Therapies at World Orphan Drug Congress USA
26/04/2018
SAN DIEGO, April 26, 2018 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc., a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, provided an overview of its non- [...]
The Joint Corp. to Host Conference Call on Thursday, May 10, to Discuss First Quarter 2018 Results
26/04/2018
SCOTTSDALE, Ariz., April 26, 2018 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT ), a national operator, manager and franchisor of chiropractic clinics, announced it will report its first quarter 2018 financial [...]
CrownBio Launches New Humanized Target Model for Immunotherapy
26/04/2018
SAN DIEGO, April 26, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing [...]
BioSig Technologies to Partner with High Lantern Group
26/04/2018
Leading global communication experts to lend support to BioSig’s growth strategy Santa Monica, CA, April 26, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a [...]
AMAG Pharmaceuticals to Host First Quarter 2018 Financial Results Conference Call and Webcast on Thursday, May 3, 2018 at 8:00 a.m. ET
26/04/2018
WALTHAM, Mass., April 26, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) today announced that its first quarter 2018 financial results will be released on Thursday, May 3, 2018 before the U.S. [...]
Corbus Pharmaceuticals to Present at the Deutsche Bank 43rd Annual Health Care Conference
26/04/2018
Live audio presentation and webcast on Wednesday, May 9th at 11:20 a.m. EDT NORWOOD, Mass., April 26, 2018 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP ) ("Corbus" or the "Company"), a [...]
Intra-Cellular Therapies Presents Data on ITI-214 at the 2018 American Academy of Neurology Annual Meeting
26/04/2018
Phase 1/2 clinical trial in patients with Parkinson's disease (PD) expanded to add additional cohort. NEW YORK, April 26, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ), a biopharmaceutical [...]
Precipio Announces Participation Details for Upcoming Shareholder Conference Call
26/04/2018
NEW HAVEN, Conn., April 26, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO ), provides details of its previously announced upcoming shareholder conference call scheduled for Monday [...]
Cutera to Present at the 2018 UBS Global Healthcare Conference
26/04/2018
BRISBANE, Calif., April 26, 2018 (GLOBE NEWSWIRE) -- Cutera, Inc. (Nasdaq: CUTR ), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, announced today that James Reinstein, [...]
eFFECTOR Publishes the Design and Profile of eFT508 in Peer Reviewed Journal of Medicinal Chemistry
26/04/2018
SAN DIEGO, April 26, 2018 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulators (STRs) for the treatment of cancer, today announced that research describing the [...]
Amicus Therapeutics to Announce First Quarter 2018 Financial Results on May 8, 2018
26/04/2018
CRANBURY, N.J., April 26, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD ) today announced a conference call and live audio webcast on Tuesday, May 8, 2018 at 8:30 a.m. ET to discuss financial results for [...]
Flexion Therapeutics Presents Updated Results from Clinical Trial Evaluating Repeat Administration of ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) at Osteoarthritis Research Society International World Congress
26/04/2018
Average time to second administration was more than 16 weeks 74% of patients received second administration of ZILRETTA between Weeks 16 and 24 Results indicate robust treatment response in a “real-world” patient group [...]
Meridian Bioscience Reports Second Quarter 2018 Operating Results, Declares Regular Second Quarter Cash Dividend, and Updates Fiscal 2018 Guidance
26/04/2018
CINCINNATI, April 26, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO ) today: GENERAL HIGHLIGHTS Reported record fiscal 2018 second quarter and first six months net revenues of $56.5 million and $108.7 [...]

Pages